Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adrabetadex in NPC1 (Part C)
NCT04958642Phase 3Terminated
- Sponsor
- Mandos Health
- Start
- Dec 2015
- Primary completion
- Apr 2022
- Modality
- Nanoparticles, Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of Trappsol Cyclo in Niemann-Pick disease type C1 (NPC1), sponsored by Mandos Health. Started Dec 2015; status: terminated.
02
Drugs
Trappsol Cyclo
03
Conditions
Niemann-Pick disease type C1 (NPC1)
Beyond the preview
Go deeper on NCT04958642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04958642.